Review



cd45.1 wt mice  (POSTECH Inc)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    POSTECH Inc cd45.1 wt mice
    Cd45.1 Wt Mice, supplied by POSTECH Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cd45.1 wt mice/product/POSTECH Inc
    Average 90 stars, based on 1 article reviews
    cd45.1 wt mice - by Bioz Stars, 2026-06
    90/100 stars

    Images



    Similar Products

    c57bl/6j wt, pmel, ot-i, gpx4 fl/fl , cd4-cre, cd90.1, cd45.1, and c57bl/6 scid mice  (Jackson Laboratory)
    90
    Jackson Laboratory c57bl/6j wt, pmel, ot-i, gpx4 fl/fl , cd4-cre, cd90.1, cd45.1, and c57bl/6 scid mice
    C57bl/6j Wt, Pmel, Ot I, Gpx4 Fl/Fl , Cd4 Cre, Cd90.1, Cd45.1, And C57bl/6 Scid Mice, supplied by Jackson Laboratory, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/c57bl/6j wt, pmel, ot-i, gpx4 fl/fl , cd4-cre, cd90.1, cd45.1, and c57bl/6 scid mice/product/Jackson Laboratory
    Average 90 stars, based on 1 article reviews
    c57bl/6j wt, pmel, ot-i, gpx4 fl/fl , cd4-cre, cd90.1, cd45.1, and c57bl/6 scid mice - by Bioz Stars, 2026-06
    90/100 stars
    		  Buy from Supplier
    cd45.1 + tet2 wt mice in the c57bl/6 j background (strain name: b6.sjl-ptprca pepcb/boyj)  (Jackson Laboratory)
    90
    Jackson Laboratory cd45.1 + tet2 wt mice in the c57bl/6 j background (strain name: b6.sjl-ptprca pepcb/boyj)
    Cd45.1 + Tet2 Wt Mice In The C57bl/6 J Background (Strain Name: B6.Sjl Ptprca Pepcb/Boyj), supplied by Jackson Laboratory, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cd45.1 + tet2 wt mice in the c57bl/6 j background (strain name: b6.sjl-ptprca pepcb/boyj)/product/Jackson Laboratory
    Average 90 stars, based on 1 article reviews
    cd45.1 + tet2 wt mice in the c57bl/6 j background (strain name: b6.sjl-ptprca pepcb/boyj) - by Bioz Stars, 2026-06
    90/100 stars
    		  Buy from Supplier
    c57bl/6/j wild-type ( wt ) and congenic cd45.1 + foxp3 gfp mice  (Jackson Laboratory)
    90
    Jackson Laboratory c57bl/6/j wild-type ( wt ) and congenic cd45.1 + foxp3 gfp mice
    C57bl/6/J Wild Type ( Wt ) And Congenic Cd45.1 + Foxp3 Gfp Mice, supplied by Jackson Laboratory, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/c57bl/6/j wild-type ( wt ) and congenic cd45.1 + foxp3 gfp mice/product/Jackson Laboratory
    Average 90 stars, based on 1 article reviews
    c57bl/6/j wild-type ( wt ) and congenic cd45.1 + foxp3 gfp mice - by Bioz Stars, 2026-06
    90/100 stars
    		  Buy from Supplier
    c57bl/6j wt cd45.1+/+ congenic strains) mice  (Jackson Laboratory)
    90
    Jackson Laboratory c57bl/6j wt cd45.1+/+ congenic strains) mice
    (A) Experimental setup. (B) Tissue distribution of the adoptively transferred anti-hCEA mouse CAR-T cell at 24h after adoptive transfer (the percentages of control vs. fucosylated cells in total CAR-T cells in the tissue were shown). (C) Experimental setup and (D) flow cytometry analysis to distinguish transferred T cells that have entered tumor parenchyma from T cells in blood vasculature. (E) Distribution of fucosylated CAR-T cells in the MC38hCEA tumor analyzed by immunofluorescence, tumor #1, scale bar: 100 μm. In vivo antitumor efficacy (F) of CAR-T cells with or without fucosylation against MC38-hCEA colon cancer and mouse survival (G). 1×10 6 MC38hCEA tumor cells were subcutaneously injected into the <t>C57BL/6J</t> mice and 0.7×10 6 CAR-T cells were transferred into the recipient mice on day8 after tumor inoculation with lymphocyte depletion by irradiation with a dose of 5 Gy before CAR-T cell transfer. IV, intravenously injection. Grey arrows indicate the intraperitoneal anti-mouse IL-6 injection (150 ug/mouse). 5–6 repeats for each group (n=5–6), nsP > 0.05; *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001; survival curves were analyzed by log-rank test and other analysis used student T-test, and mean ±standard deviation (SD) values of biological replicates.
    C57bl/6j Wt Cd45.1+/+ Congenic Strains) Mice, supplied by Jackson Laboratory, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/c57bl/6j wt cd45.1+/+ congenic strains) mice/product/Jackson Laboratory
    Average 90 stars, based on 1 article reviews
    c57bl/6j wt cd45.1+/+ congenic strains) mice - by Bioz Stars, 2026-06
    90/100 stars
    		  Buy from Supplier
    cd45.1 wt mice  (POSTECH Inc)
    90
    POSTECH Inc cd45.1 wt mice
    (A) Experimental setup. (B) Tissue distribution of the adoptively transferred anti-hCEA mouse CAR-T cell at 24h after adoptive transfer (the percentages of control vs. fucosylated cells in total CAR-T cells in the tissue were shown). (C) Experimental setup and (D) flow cytometry analysis to distinguish transferred T cells that have entered tumor parenchyma from T cells in blood vasculature. (E) Distribution of fucosylated CAR-T cells in the MC38hCEA tumor analyzed by immunofluorescence, tumor #1, scale bar: 100 μm. In vivo antitumor efficacy (F) of CAR-T cells with or without fucosylation against MC38-hCEA colon cancer and mouse survival (G). 1×10 6 MC38hCEA tumor cells were subcutaneously injected into the <t>C57BL/6J</t> mice and 0.7×10 6 CAR-T cells were transferred into the recipient mice on day8 after tumor inoculation with lymphocyte depletion by irradiation with a dose of 5 Gy before CAR-T cell transfer. IV, intravenously injection. Grey arrows indicate the intraperitoneal anti-mouse IL-6 injection (150 ug/mouse). 5–6 repeats for each group (n=5–6), nsP > 0.05; *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001; survival curves were analyzed by log-rank test and other analysis used student T-test, and mean ±standard deviation (SD) values of biological replicates.
    Cd45.1 Wt Mice, supplied by POSTECH Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cd45.1 wt mice/product/POSTECH Inc
    Average 90 stars, based on 1 article reviews
    cd45.1 wt mice - by Bioz Stars, 2026-06
    90/100 stars
    		  Buy from Supplier
    cd45.1 wt mice  (Taconic Biosciences)
    90
    Taconic Biosciences cd45.1 wt mice
    (A) Experimental setup. (B) Tissue distribution of the adoptively transferred anti-hCEA mouse CAR-T cell at 24h after adoptive transfer (the percentages of control vs. fucosylated cells in total CAR-T cells in the tissue were shown). (C) Experimental setup and (D) flow cytometry analysis to distinguish transferred T cells that have entered tumor parenchyma from T cells in blood vasculature. (E) Distribution of fucosylated CAR-T cells in the MC38hCEA tumor analyzed by immunofluorescence, tumor #1, scale bar: 100 μm. In vivo antitumor efficacy (F) of CAR-T cells with or without fucosylation against MC38-hCEA colon cancer and mouse survival (G). 1×10 6 MC38hCEA tumor cells were subcutaneously injected into the <t>C57BL/6J</t> mice and 0.7×10 6 CAR-T cells were transferred into the recipient mice on day8 after tumor inoculation with lymphocyte depletion by irradiation with a dose of 5 Gy before CAR-T cell transfer. IV, intravenously injection. Grey arrows indicate the intraperitoneal anti-mouse IL-6 injection (150 ug/mouse). 5–6 repeats for each group (n=5–6), nsP > 0.05; *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001; survival curves were analyzed by log-rank test and other analysis used student T-test, and mean ±standard deviation (SD) values of biological replicates.
    Cd45.1 Wt Mice, supplied by Taconic Biosciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cd45.1 wt mice/product/Taconic Biosciences
    Average 90 stars, based on 1 article reviews
    cd45.1 wt mice - by Bioz Stars, 2026-06
    90/100 stars
    		  Buy from Supplier
    cd45.1+/+ congenic wt mice  (Jackson Laboratory)
    90
    Jackson Laboratory cd45.1+/+ congenic wt mice
    (A) Experimental setup. (B) Tissue distribution of the adoptively transferred anti-hCEA mouse CAR-T cell at 24h after adoptive transfer (the percentages of control vs. fucosylated cells in total CAR-T cells in the tissue were shown). (C) Experimental setup and (D) flow cytometry analysis to distinguish transferred T cells that have entered tumor parenchyma from T cells in blood vasculature. (E) Distribution of fucosylated CAR-T cells in the MC38hCEA tumor analyzed by immunofluorescence, tumor #1, scale bar: 100 μm. In vivo antitumor efficacy (F) of CAR-T cells with or without fucosylation against MC38-hCEA colon cancer and mouse survival (G). 1×10 6 MC38hCEA tumor cells were subcutaneously injected into the <t>C57BL/6J</t> mice and 0.7×10 6 CAR-T cells were transferred into the recipient mice on day8 after tumor inoculation with lymphocyte depletion by irradiation with a dose of 5 Gy before CAR-T cell transfer. IV, intravenously injection. Grey arrows indicate the intraperitoneal anti-mouse IL-6 injection (150 ug/mouse). 5–6 repeats for each group (n=5–6), nsP > 0.05; *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001; survival curves were analyzed by log-rank test and other analysis used student T-test, and mean ±standard deviation (SD) values of biological replicates.
    Cd45.1+/+ Congenic Wt Mice, supplied by Jackson Laboratory, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cd45.1+/+ congenic wt mice/product/Jackson Laboratory
    Average 90 stars, based on 1 article reviews
    cd45.1+/+ congenic wt mice - by Bioz Stars, 2026-06
    90/100 stars
    		  Buy from Supplier
    cd45.1 +/+ congenic wt mice cbyj.sjl(b6)-ptprca/j  (Jackson Laboratory)
    90
    Jackson Laboratory cd45.1 +/+ congenic wt mice cbyj.sjl(b6)-ptprca/j
    (A) Experimental setup. (B) Tissue distribution of the adoptively transferred anti-hCEA mouse CAR-T cell at 24h after adoptive transfer (the percentages of control vs. fucosylated cells in total CAR-T cells in the tissue were shown). (C) Experimental setup and (D) flow cytometry analysis to distinguish transferred T cells that have entered tumor parenchyma from T cells in blood vasculature. (E) Distribution of fucosylated CAR-T cells in the MC38hCEA tumor analyzed by immunofluorescence, tumor #1, scale bar: 100 μm. In vivo antitumor efficacy (F) of CAR-T cells with or without fucosylation against MC38-hCEA colon cancer and mouse survival (G). 1×10 6 MC38hCEA tumor cells were subcutaneously injected into the <t>C57BL/6J</t> mice and 0.7×10 6 CAR-T cells were transferred into the recipient mice on day8 after tumor inoculation with lymphocyte depletion by irradiation with a dose of 5 Gy before CAR-T cell transfer. IV, intravenously injection. Grey arrows indicate the intraperitoneal anti-mouse IL-6 injection (150 ug/mouse). 5–6 repeats for each group (n=5–6), nsP > 0.05; *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001; survival curves were analyzed by log-rank test and other analysis used student T-test, and mean ±standard deviation (SD) values of biological replicates.
    Cd45.1 +/+ Congenic Wt Mice Cbyj.Sjl(b6) Ptprca/J, supplied by Jackson Laboratory, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cd45.1 +/+ congenic wt mice cbyj.sjl(b6)-ptprca/j/product/Jackson Laboratory
    Average 90 stars, based on 1 article reviews
    cd45.1 +/+ congenic wt mice cbyj.sjl(b6)-ptprca/j - by Bioz Stars, 2026-06
    90/100 stars
    		  Buy from Supplier
    male wt (wild-type, c57bl/6), gfp-c57bl/6, cd45.1 congenic c57bl/6 mice  (Jackson Laboratory)
    90
    Jackson Laboratory male wt (wild-type, c57bl/6), gfp-c57bl/6, cd45.1 congenic c57bl/6 mice
    (A) Experimental setup. (B) Tissue distribution of the adoptively transferred anti-hCEA mouse CAR-T cell at 24h after adoptive transfer (the percentages of control vs. fucosylated cells in total CAR-T cells in the tissue were shown). (C) Experimental setup and (D) flow cytometry analysis to distinguish transferred T cells that have entered tumor parenchyma from T cells in blood vasculature. (E) Distribution of fucosylated CAR-T cells in the MC38hCEA tumor analyzed by immunofluorescence, tumor #1, scale bar: 100 μm. In vivo antitumor efficacy (F) of CAR-T cells with or without fucosylation against MC38-hCEA colon cancer and mouse survival (G). 1×10 6 MC38hCEA tumor cells were subcutaneously injected into the <t>C57BL/6J</t> mice and 0.7×10 6 CAR-T cells were transferred into the recipient mice on day8 after tumor inoculation with lymphocyte depletion by irradiation with a dose of 5 Gy before CAR-T cell transfer. IV, intravenously injection. Grey arrows indicate the intraperitoneal anti-mouse IL-6 injection (150 ug/mouse). 5–6 repeats for each group (n=5–6), nsP > 0.05; *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001; survival curves were analyzed by log-rank test and other analysis used student T-test, and mean ±standard deviation (SD) values of biological replicates.
    Male Wt (Wild Type, C57bl/6), Gfp C57bl/6, Cd45.1 Congenic C57bl/6 Mice, supplied by Jackson Laboratory, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/male wt (wild-type, c57bl/6), gfp-c57bl/6, cd45.1 congenic c57bl/6 mice/product/Jackson Laboratory
    Average 90 stars, based on 1 article reviews
    male wt (wild-type, c57bl/6), gfp-c57bl/6, cd45.1 congenic c57bl/6 mice - by Bioz Stars, 2026-06
    90/100 stars
    		  Buy from Supplier
    b6.sjl-ptprcapepcb/boy (wt cd45.1) mice  (Charles River Laboratories)
    90
    Charles River Laboratories b6.sjl-ptprcapepcb/boy (wt cd45.1) mice
    (A) Experimental setup. (B) Tissue distribution of the adoptively transferred anti-hCEA mouse CAR-T cell at 24h after adoptive transfer (the percentages of control vs. fucosylated cells in total CAR-T cells in the tissue were shown). (C) Experimental setup and (D) flow cytometry analysis to distinguish transferred T cells that have entered tumor parenchyma from T cells in blood vasculature. (E) Distribution of fucosylated CAR-T cells in the MC38hCEA tumor analyzed by immunofluorescence, tumor #1, scale bar: 100 μm. In vivo antitumor efficacy (F) of CAR-T cells with or without fucosylation against MC38-hCEA colon cancer and mouse survival (G). 1×10 6 MC38hCEA tumor cells were subcutaneously injected into the <t>C57BL/6J</t> mice and 0.7×10 6 CAR-T cells were transferred into the recipient mice on day8 after tumor inoculation with lymphocyte depletion by irradiation with a dose of 5 Gy before CAR-T cell transfer. IV, intravenously injection. Grey arrows indicate the intraperitoneal anti-mouse IL-6 injection (150 ug/mouse). 5–6 repeats for each group (n=5–6), nsP > 0.05; *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001; survival curves were analyzed by log-rank test and other analysis used student T-test, and mean ±standard deviation (SD) values of biological replicates.
    B6.Sjl Ptprcapepcb/Boy (Wt Cd45.1) Mice, supplied by Charles River Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/b6.sjl-ptprcapepcb/boy (wt cd45.1) mice/product/Charles River Laboratories
    Average 90 stars, based on 1 article reviews
    b6.sjl-ptprcapepcb/boy (wt cd45.1) mice - by Bioz Stars, 2026-06
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    (A) Experimental setup. (B) Tissue distribution of the adoptively transferred anti-hCEA mouse CAR-T cell at 24h after adoptive transfer (the percentages of control vs. fucosylated cells in total CAR-T cells in the tissue were shown). (C) Experimental setup and (D) flow cytometry analysis to distinguish transferred T cells that have entered tumor parenchyma from T cells in blood vasculature. (E) Distribution of fucosylated CAR-T cells in the MC38hCEA tumor analyzed by immunofluorescence, tumor #1, scale bar: 100 μm. In vivo antitumor efficacy (F) of CAR-T cells with or without fucosylation against MC38-hCEA colon cancer and mouse survival (G). 1×10 6 MC38hCEA tumor cells were subcutaneously injected into the C57BL/6J mice and 0.7×10 6 CAR-T cells were transferred into the recipient mice on day8 after tumor inoculation with lymphocyte depletion by irradiation with a dose of 5 Gy before CAR-T cell transfer. IV, intravenously injection. Grey arrows indicate the intraperitoneal anti-mouse IL-6 injection (150 ug/mouse). 5–6 repeats for each group (n=5–6), nsP > 0.05; *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001; survival curves were analyzed by log-rank test and other analysis used student T-test, and mean ±standard deviation (SD) values of biological replicates.

    Journal: bioRxiv

    Article Title: Enforced E-selectin ligand installation enhances homing and efficacy of adoptively transferred T cells

    doi: 10.1101/2025.01.12.632650

    Figure Lengend Snippet: (A) Experimental setup. (B) Tissue distribution of the adoptively transferred anti-hCEA mouse CAR-T cell at 24h after adoptive transfer (the percentages of control vs. fucosylated cells in total CAR-T cells in the tissue were shown). (C) Experimental setup and (D) flow cytometry analysis to distinguish transferred T cells that have entered tumor parenchyma from T cells in blood vasculature. (E) Distribution of fucosylated CAR-T cells in the MC38hCEA tumor analyzed by immunofluorescence, tumor #1, scale bar: 100 μm. In vivo antitumor efficacy (F) of CAR-T cells with or without fucosylation against MC38-hCEA colon cancer and mouse survival (G). 1×10 6 MC38hCEA tumor cells were subcutaneously injected into the C57BL/6J mice and 0.7×10 6 CAR-T cells were transferred into the recipient mice on day8 after tumor inoculation with lymphocyte depletion by irradiation with a dose of 5 Gy before CAR-T cell transfer. IV, intravenously injection. Grey arrows indicate the intraperitoneal anti-mouse IL-6 injection (150 ug/mouse). 5–6 repeats for each group (n=5–6), nsP > 0.05; *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001; survival curves were analyzed by log-rank test and other analysis used student T-test, and mean ±standard deviation (SD) values of biological replicates.

    Article Snippet: C57BL/6J (both WT and CD45.1+/+ congenic strains) mice were purchased from Jackson Laboratory.

    Techniques: Adoptive Transfer Assay, Control, Flow Cytometry, Immunofluorescence, In Vivo, Injection, Irradiation, Standard Deviation

    (A) Bone marrow metastasis was established by tail caudal artery injection, and control or fucosylated OT-I cells were transferred into metastasis bearing mice. (B) OT-I cell number in different organs at 24h after the cell transfer. (C) Control or fucosylated OT-I cells were transferred into the mice at 6–8h after challenged by E0771-OVA cells by IV injection and (D) OT-I cell number in different organs were analyzed at 24h after the cell transfer. (E-H) Cell-surface fucosylation improves CAR-T cell efficacy by enhancing T cell infiltration in E0771-E5 tumor. 1×10 6 E0771-E5 tumor cells were subcutaneously injected into the C57BL/6J mice and 1×10 6 E0771-E5 expressing luciferase were intravenously injected into the same mice. CAR-T cells were transferred into the mice on day8 after tumor injection with lymphocytes deletion by irradiation with a dose of 5 Gy before the CAR-T cell transfer. IV, intravenously injection. Lung metastasis was tracked by IVIS (E-H), tumor size (I), survival curves (J) and complete response (K) were recorded. 5–7 repeats for each group (n=5–7), nsP > 0.05; *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001; tumor size was analyzed by student T-test and survival curves were analyzed by log-rank test. Mean ±standard deviation (SD) values of biological replicates.

    Journal: bioRxiv

    Article Title: Enforced E-selectin ligand installation enhances homing and efficacy of adoptively transferred T cells

    doi: 10.1101/2025.01.12.632650

    Figure Lengend Snippet: (A) Bone marrow metastasis was established by tail caudal artery injection, and control or fucosylated OT-I cells were transferred into metastasis bearing mice. (B) OT-I cell number in different organs at 24h after the cell transfer. (C) Control or fucosylated OT-I cells were transferred into the mice at 6–8h after challenged by E0771-OVA cells by IV injection and (D) OT-I cell number in different organs were analyzed at 24h after the cell transfer. (E-H) Cell-surface fucosylation improves CAR-T cell efficacy by enhancing T cell infiltration in E0771-E5 tumor. 1×10 6 E0771-E5 tumor cells were subcutaneously injected into the C57BL/6J mice and 1×10 6 E0771-E5 expressing luciferase were intravenously injected into the same mice. CAR-T cells were transferred into the mice on day8 after tumor injection with lymphocytes deletion by irradiation with a dose of 5 Gy before the CAR-T cell transfer. IV, intravenously injection. Lung metastasis was tracked by IVIS (E-H), tumor size (I), survival curves (J) and complete response (K) were recorded. 5–7 repeats for each group (n=5–7), nsP > 0.05; *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001; tumor size was analyzed by student T-test and survival curves were analyzed by log-rank test. Mean ±standard deviation (SD) values of biological replicates.

    Article Snippet: C57BL/6J (both WT and CD45.1+/+ congenic strains) mice were purchased from Jackson Laboratory.

    Techniques: Injection, Control, IV Injection, Expressing, Luciferase, Irradiation, Standard Deviation

    Reagents and antibodies

    Journal: bioRxiv

    Article Title: Enforced E-selectin ligand installation enhances homing and efficacy of adoptively transferred T cells

    doi: 10.1101/2025.01.12.632650

    Figure Lengend Snippet: Reagents and antibodies

    Article Snippet: C57BL/6J (both WT and CD45.1+/+ congenic strains) mice were purchased from Jackson Laboratory.

    Techniques: Recombinant, Cell Isolation